Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OV PRECISION: A Randomized Controlled Swiss Trial Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy in Ovarian Cancer.

NCT06466382 is registered in ClinicalTrials.gov with Swiss GO Trial Group as lead sponsor.

NCT NCT06466382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06466382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OV PRECISION: A Randomized Controlled Swiss Trial Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy in Ovarian Cancer.
Lead sponsor
Swiss GO Trial Group
Phase
Not applicable
Overall status
Recruiting
Start date
March 31, 2025
Completion date
September 30, 2028
Enrollment
60 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube neoplasms, high-grade serous ovarian carcinoma (hgsoc), ovarian endometrioid carcinoma, ovarian neoplasm epithelial